INTRACELLULAR TRAFFICKING OF PLURONIC MICELLES
169
in drug-sensitive cells, suggesting a higher sensi-
tivity of drug-resistant cells to the action of
polymeric surfactants. The permeabilization of
acidic vesicles caused dramatic changes of the
intracellular localization of the anthracyclin drug
Rb. When delivered in PBS, the drug was
excluded from the nuclei of MDR cells, whereas
delivery in Pluronic micelles resulted in drug
release from the cytoplasmic vesicles and cell
membranes and accumulation in cell nuclei. Drug
delivery in Pluronic micelles combined with the
application of ultrasound substantially increased
drug uptake by the MDR cells. These ®ndings
suggest that the nuclear accumulation of drugs
internalized via ¯uid-phase endocytosis can be
enhanced by the application of Pluronic micelles
and can be further augmented by ultrasonic
irradiation.
7. Munshi N, Rapoport N, Pitt WG. 1997. Ultrasonic
activated drug delivery from Pluronic P-105
micelles. Cancer Lett 118:13±19.
8. Rapoport NY, Herron JN, Pitt WG, Pitina L. 1999.
Micellar delivery of doxorubicin and its paramag-
netic analog, ruboxyl, to HL-60: Effect of micelle
structure and ultrasound on the intracellular drug
uptake. J Controlled Release 58:153±162.
9. Husseni GA, Myrup GD, Pitt WG, Christensen DA,
Rapoport NY. 2000. Factor affecting acoustically
triggered release of drugs from polymeric micelles.
J Controlled Release 69:43±52.
10. Rapoport N, Marin AP, Timoshin AA. 2000. Effect
of a polymeric surfactant on electron transport
in HL-60 cells. Arch Biochem Biophys 384:100±
108.
11. Marin A, Muniruzzaman M, Rapoport N. 2001.
Acoustic activation of drug delivery from polymeric
micelles: Effect of pulsed ultrasound. J Controlled
Release 71:239±249.
12. Marin A, Muniruzzaman M, Rapoport N. 2001.
Mechanism of the ultrasound activation of micellar
drug delivery. J Controlled Release 75:69±81.
13. Muniruzzaman Md, Marin A, Luo Y, Prestwich GP,
Pitt WG, Husseini G, Rapoport N. Intracellular
uptake of Pluronic unimers and micelles: Effect of
the aggregation state and ultrasound. Colloids
Surfaces B: Biointerfaces, in press.
14. Miller DW, Batrakova EV, Kabanov AV. 1999.
Inhibition of multidrug resistance-associated pro-
tein (MPR) functional activity with pluronic block
copolymers. Pharm Res 16:396±401.
ACKNOWLEDGMENTS
This work was supported by the NIH grant R01
CA76562-01A1. Productive discussions with
Dr. A. Kabanov are greatly appreciated. The
authors acknowledge valuable editorial com-
ments of Dr. D.A. Christensen.
REFERENCES
15. Reynolds T. 1995. Polymers help guide cancer
drugs to tumor targets- and keep them there. J
Natl Cancer Inst 87:1582±1584.
1. Maeda H, Seymour LM, Miyamoto Y. 1992. Con-
jugates of anticancer agents and polymers: advan-
tages of macromolecular therapeutics in vivo.
Bioconjugate Chem 3:351±362.
16. Benderra Z, Morjani H, Trussardi A, Manfait M.
1998. Characterization of H -ATPase-dependent
activity of multidrug resistance-associated protein
in homoharringtonine-resistant human leukemic
K562 cells. Leukemia 10:1539±1544.
2. Kwon GS, Kataoka K. 1995. Block copolymer
micelles as long circulating drug vehicles. Adv
Drug Deliv Rev 16:295±309.
17. Altan N, Chen Y, Schindler M, Simon SM. 1998.
Defective acidi®cation in human Breast tumor cells
and implications for chemotherapy. J Exp Med
187:1583±1598.
18. Asta®eva I, Maksimova I, Lukanidin E, Alakhov V,
Kabanov A. 1996. Enhancement of the polycation-
mediated DNA uptake and cell transfection with
Pluronic P85 block copolymer. FEBS Lett 389:278±
280.
19. Lemieux P, Guerin N, Proulx R, Chistyakova L,
Kabanov A, Alakhov V. 2000. A combination of
poloxamers increases gene expression of plasmid
DNA in skeletal muscle. Gene Ther 7:986±991.
20. Lemieux P, Vinogradov SV, Gebhart CL, Guerin N,
Paradis G, Nguyen H-K, Ochetti B, Suzdaltzeva
YG, Batrakova EV, Bronich TK, St-Pierre Y,
Alakhov VYu, Kabanov AV. 2000. Block and graft
copolymers and nanogel copolymer networks
3. Kataoka K, Matsumoto T, Yokoyama M, Okano T,
Sakurai Y, Fukushima S, Okamoto K, Kwon GS.
2000. Doxorubicin-loaded poly(ethylene glycol)-
poly(b-benzyl-L-aspartate) copolymer micelles:
Their pharmaceutical characteristics and biological
signi®cance. J Controlled Release 64:143±153.
4. Rapoport N. 1999. Stabilization and activation of
Pluronic micelles for tumor-targeted drug delivery.
Colloids Surface B: Biointerfaces 3:93±111.
5. Rapoport N, Munsh N, Pitina L, Pitt WG. 1997.
Pluronic micelles as vehicles for tumor-speci®c
delivery of two anticancer drugs to HL-60 cells
using acoustic activation. Polym Preprints 38:620±
621.
6. Rapoport N, Pitina L. 1998. Intracellular distribu-
tion and intracellular dynamics of a spin-labeled
analogue of doxorubicin by ¯uorescence and EPR
spectroscopy. J Pharm Sci 87:321±325.
JOURNAL OF PHARMACEUTICAL SCIENCES, VOL. 91, NO. 1, JANUARY 2002